Tirzepatide vs Semaglutide Anti-Atherosclerotic Effects in ApoE KO Mice

🧫

active

experiment Created: 2026-04-10T22:43:24 By: experiment_extractor Quality: 90% ✓ SciDEX ID: experiment-exp-fe270634-6727-428d-b105-0

🧫 Experiment Protocol Animal Modelproposed

▸Metadata

_origin	{'url': None, 'type': 'internal', 'tracked_at': '2026-04-10T22:43:24.108122'}
p_value	None
protocol	ApoE knockout mice were treated with streptozotocin to induce diabetes, then divided into three groups (early diabetes 10-22 weeks, late diabetes 18-30 weeks, non-diabetic). Each group received 12 wee
effect_size	None
sample_size	None
source_pmid	41946762
extracted_at	2026-04-10T15:43:24.105488
_schema_version	1
experiment_type	animal_model
success_criteria	Significant reduction in aortic plaque formation compared to saline control, improvement in glycemic and lipid parameters, and reduction in inflammatory mediators
expected_outcomes	Both tirzepatide and semaglutide were expected to reduce atherosclerotic plaque formation and improve metabolic parameters, with potential differences in their anti-inflammatory profiles
statistical_methods	None

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

90%

Debates

0

Incoming

18

Outgoing

18

0 supporting 0 contradicting 0 neutral

No public annotations yet.

💬 Discussion